Two leading health-tech companies, Diagnose.me and DNA ERA, have joined forces with a clear goal – to improve the health of as many people as possible through innovative solutions. This partnership brings a unique combination of two approaches: advanced medical diagnostics and personalized prevention based on DNA analysis. Together, they want to help members of their communities not only manage health problems, but also prevent them.
The union of two leaders in the health-tech sector
Diagnose.me is known for its global approach to medical care. It allows patients to consult their health problems with experts from renowned clinics around the world, without language barriers. On the other hand, DNA ERA focuses on genetic analysis, which helps to reveal predispositions to health problems, which opens the door to personalized solutions.
The combination of these two approaches offers a unique opportunity for comprehensive care. Clients can now receive services that combine the best diagnostics with preventive programs that help maintain a healthy lifestyle.
In addition, this cooperation brings DNA ERA access to 17 countries where Diagnose.me is already active. This means more options for people who want to invest in their health. Whether it is Slovakia, the Czech Republic, Poland, or the wider European market, the goal is to adapt to the specifics of individual countries while taking advantage of global trends such as prevention and longevity.
From prevention to cutting-edge diagnostics
Prevention is more important than ever these days. People are realizing the value of early detection of health risks and adapting their lifestyle. In this regard, DNA ERA brings its know-how – genetic predisposition analysis, which helps identify risks that could affect your health. Through this information, personalized solutions can be designed to support your health.
The combined forces of Diagnose.me and DNA ERA open up new possibilities for clients. While Diagnose.me helps solve existing health problems, DNA ERA focuses on how to prevent these problems. Together, they provide a comprehensive approach that includes everything from genetic prevention to advanced medical care.
It’s important to be one step ahead
The shared vision of both companies is to push the boundaries of healthcare and make innovations accessible to the general public. They consider it key to constantly innovate and be one step ahead of the possibilities of public healthcare. Both companies see an opportunity not only in strengthening their own services, but also in the possible integration of other startups in the health tech sector, which could expand their offer and consolidate their position as leaders in personalized medicine.